BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

276 related articles for article (PubMed ID: 17909271)

  • 1. Emerging pharmacologic options for treating postoperative ileus.
    Kraft MD
    Am J Health Syst Pharm; 2007 Oct; 64(20 Suppl 13):S13-20. PubMed ID: 17909271
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Methylnaltrexone, a new peripherally acting mu-opioid receptor antagonist being evaluated for the treatment of postoperative ileus.
    Kraft MD
    Expert Opin Investig Drugs; 2008 Sep; 17(9):1365-77. PubMed ID: 18694369
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The selective mu opioid receptor antagonist, alvimopan, improves delayed GI transit of postoperative ileus in rats.
    Fukuda H; Suenaga K; Tsuchida D; Mantyh CR; Pappas TN; Hicks GA; Dehaven-Hudkins DL; Takahashi T
    Brain Res; 2006 Aug; 1102(1):63-70. PubMed ID: 16797494
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Peripherally acting mu-opioid receptor antagonists and postoperative ileus: mechanisms of action and clinical applicability.
    Viscusi ER; Gan TJ; Leslie JB; Foss JF; Talon MD; Du W; Owens G
    Anesth Analg; 2009 Jun; 108(6):1811-22. PubMed ID: 19448206
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Current choices--good or bad--for the proactive management of postoperative ileus: A surgeon's view.
    Saclarides TJ
    J Perianesth Nurs; 2006 Apr; 21(2A Suppl):S7-15. PubMed ID: 16597534
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Peripherally Acting μ-Opioid Receptor Antagonists in the Management of Postoperative Ileus: a Clinical Review.
    Chamie K; Golla V; Lenis AT; Lec PM; Rahman S; Viscusi ER
    J Gastrointest Surg; 2021 Jan; 25(1):293-302. PubMed ID: 32779081
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Peripherally acting mu-opioid-receptor antagonists and the connection between postoperative ileus and pain management: The anesthesiologist's view and beyond.
    Sinatra RS
    J Perianesth Nurs; 2006 Apr; 21(2A Suppl):S16-23. PubMed ID: 16597531
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Postoperative ileus-related morbidity profile in patients treated with alvimopan after bowel resection.
    Wolff BG; Weese JL; Ludwig KA; Delaney CP; Stamos MJ; Michelassi F; Du W; Techner L
    J Am Coll Surg; 2007 Apr; 204(4):609-16. PubMed ID: 17382220
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Efficacy of Peripheral Opioid Antagonists in Opioid-Induced Constipation and Postoperative Ileus: A Systematic Review of the Literature.
    Schwenk ES; Grant AE; Torjman MC; McNulty SE; Baratta JL; Viscusi ER
    Reg Anesth Pain Med; 2017; 42(6):767-777. PubMed ID: 29016552
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Off-label uses of alvimopan and methylnaltrexone.
    Rodriguez RW
    Am J Health Syst Pharm; 2014 Sep; 71(17):1450-5. PubMed ID: 25147168
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Alvimopan for the management of postoperative ileus.
    Leslie JB
    Ann Pharmacother; 2005 Sep; 39(9):1502-10. PubMed ID: 16076918
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alvimopan: a peripherally acting mu-opioid receptor antagonist.
    Leslie JB
    Drugs Today (Barc); 2007 Sep; 43(9):611-25. PubMed ID: 17940638
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical trial: alvimopan for the management of post-operative ileus after abdominal surgery: results of an international randomized, double-blind, multicentre, placebo-controlled clinical study.
    Büchler MW; Seiler CM; Monson JR; Flamant Y; Thompson-Fawcett MW; Byrne MM; Mortensen ER; Altman JF; Williamson R
    Aliment Pharmacol Ther; 2008 Aug; 28(3):312-25. PubMed ID: 19086236
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alvimopan, a novel, peripherally acting mu opioid antagonist: results of a multicenter, randomized, double-blind, placebo-controlled, phase III trial of major abdominal surgery and postoperative ileus.
    Wolff BG; Michelassi F; Gerkin TM; Techner L; Gabriel K; Du W; Wallin BA;
    Ann Surg; 2004 Oct; 240(4):728-34; discussion 734-5. PubMed ID: 15383800
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alvimopan, a selective peripherally acting mu-opioid antagonist.
    Camilleri M
    Neurogastroenterol Motil; 2005 Apr; 17(2):157-65. PubMed ID: 15787936
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alvimopan, for postoperative ileus following bowel resection: a pooled analysis of phase III studies.
    Delaney CP; Wolff BG; Viscusi ER; Senagore AJ; Fort JG; Du W; Techner L; Wallin B
    Ann Surg; 2007 Mar; 245(3):355-63. PubMed ID: 17435541
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Economic Impact of Alvimopan Considering Varying Definitions of Postoperative Ileus.
    Earnshaw SR; Kauf TL; McDade C; Potashman MH; Pauyo C; Reese ES; Senagore A
    J Am Coll Surg; 2015 Nov; 221(5):941-50. PubMed ID: 26353904
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel opioid antagonists for opioid-induced bowel dysfunction and postoperative ileus.
    Becker G; Blum HE
    Lancet; 2009 Apr; 373(9670):1198-206. PubMed ID: 19217656
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Alvimopan* (ADL 8-2698) is a novel peripheral opioid antagonist.
    Schmidt WK
    Am J Surg; 2001 Nov; 182(5A Suppl):27S-38S. PubMed ID: 11755894
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Alvimopan for postoperative ileus.
    Bream-Rouwenhorst HR; Cantrell MA
    Am J Health Syst Pharm; 2009 Jul; 66(14):1267-77. PubMed ID: 19574601
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.